세계의 염기 편집 시장(2024-2028년)

Abstract

The base editing market is forecasted to grow by USD 307.66 mn during 2023-2028, accelerating at a CAGR of 15.1% during the forecast period. The report on the base editing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increase in applications of genome editing in therapeutics, increasing research activities in pharmaceutical and biotechnology sectors, and increasing demand for genetically edited crops.

Technavio's base editing market is segmented as below:

By Application

• Drug discovery and development
• Agriculture
• Veterinary

By Type

• DNA base editing
• RNA base editing

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the technological advancement in genome editing tools as one of the prime reasons driving the base editing market growth during the next few years. Also, growing developments in precision medicine and gene therapy and advances in genome editing tools to improve the development of vaccines will lead to sizable demand in the market.

The report on the base editing market covers the following areas:

• Base editing market sizing
• Base editing market forecast
• Base editing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading base editing market vendors that include Beam Therapeutics Inc., Bio Palette Co. Ltd., Cellectis SA, Creative Biogene, Danaher Corp., EdiGene Inc., ElevateBio, Genkore Co. Ltd., GenScript Biotech Corp., Horizon Discovery Ltd., Intellia Therapeutics Inc., KromaTiD Inc., Maravai LifeSciences Holdings Inc., Merck KGaA, Pairwise Plants Services, PerkinElmer Inc, ProQR Therapeutics NV, QI Biodesign Biotechnology Co. Ltd., Shape Therapeutics Inc., and Synthego Corp.. Also, the base editing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global base editing market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global base editing market 2018 - 2022 ($ million)
• 4.2 Application Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
• 4.3 Type Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

• 6.1 Market segments
• Exhibit 30: Chart on Application - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
• 6.2 Comparison by Application
• Exhibit 32: Chart on Comparison by Application
• Exhibit 33: Data Table on Comparison by Application
• 6.3 Drug discovery and development - Market size and forecast 2023-2028
• Exhibit 34: Chart on Drug discovery and development - Market size and forecast 2023-2028 ($ million)
• Exhibit 35: Data Table on Drug discovery and development - Market size and forecast 2023-2028 ($ million)
• Exhibit 36: Chart on Drug discovery and development - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Drug discovery and development - Year-over-year growth 2023-2028 (%)
• 6.4 Agriculture - Market size and forecast 2023-2028
• Exhibit 38: Chart on Agriculture - Market size and forecast 2023-2028 ($ million)
• Exhibit 39: Data Table on Agriculture - Market size and forecast 2023-2028 ($ million)
• Exhibit 40: Chart on Agriculture - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Agriculture - Year-over-year growth 2023-2028 (%)
• 6.5 Veterinary - Market size and forecast 2023-2028
• Exhibit 42: Chart on Veterinary - Market size and forecast 2023-2028 ($ million)
• Exhibit 43: Data Table on Veterinary - Market size and forecast 2023-2028 ($ million)
• Exhibit 44: Chart on Veterinary - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Veterinary - Year-over-year growth 2023-2028 (%)
• 6.6 Market opportunity by Application
• Exhibit 46: Market opportunity by Application ($ million)
• Exhibit 47: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Type

• 7.1 Market segments
• Exhibit 48: Chart on Type - Market share 2023-2028 (%)
• Exhibit 49: Data Table on Type - Market share 2023-2028 (%)
• 7.2 Comparison by Type
• Exhibit 50: Chart on Comparison by Type
• Exhibit 51: Data Table on Comparison by Type
• 7.3 DNA base editing - Market size and forecast 2023-2028
• Exhibit 52: Chart on DNA base editing - Market size and forecast 2023-2028 ($ million)
• Exhibit 53: Data Table on DNA base editing - Market size and forecast 2023-2028 ($ million)
• Exhibit 54: Chart on DNA base editing - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on DNA base editing - Year-over-year growth 2023-2028 (%)
• 7.4 RNA base editing - Market size and forecast 2023-2028
• Exhibit 56: Chart on RNA base editing - Market size and forecast 2023-2028 ($ million)
• Exhibit 57: Data Table on RNA base editing - Market size and forecast 2023-2028 ($ million)
• Exhibit 58: Chart on RNA base editing - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on RNA base editing - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Type
• Exhibit 60: Market opportunity by Type ($ million)
• Exhibit 61: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 China - Market size and forecast 2023-2028
• Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.9 Germany - Market size and forecast 2023-2028
• Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.10 UK - Market size and forecast 2023-2028
• Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.11 Japan - Market size and forecast 2023-2028
• Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 103: Market opportunity By Geographical Landscape ($ million)
• Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 105: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 107: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 108: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 109: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 110: Matrix on vendor position and classification
• 12.3 Beam Therapeutics Inc.
• Exhibit 111: Beam Therapeutics Inc. - Overview
• Exhibit 112: Beam Therapeutics Inc. - Product / Service
• Exhibit 113: Beam Therapeutics Inc. - Key offerings
• 12.4 Bio Palette Co. Ltd.
• Exhibit 114: Bio Palette Co. Ltd. - Overview
• Exhibit 115: Bio Palette Co. Ltd. - Product / Service
• Exhibit 116: Bio Palette Co. Ltd. - Key offerings
• 12.5 Cellectis SA
• Exhibit 117: Cellectis SA - Overview
• Exhibit 118: Cellectis SA - Product / Service
• Exhibit 119: Cellectis SA - Key offerings
• 12.6 Creative Biogene
• Exhibit 120: Creative Biogene - Overview
• Exhibit 121: Creative Biogene - Product / Service
• Exhibit 122: Creative Biogene - Key offerings
• 12.7 Danaher Corp.
• Exhibit 123: Danaher Corp. - Overview
• Exhibit 124: Danaher Corp. - Business segments
• Exhibit 125: Danaher Corp. - Key news
• Exhibit 126: Danaher Corp. - Key offerings
• Exhibit 127: Danaher Corp. - Segment focus
• 12.8 EdiGene Inc.
• Exhibit 128: EdiGene Inc. - Overview
• Exhibit 129: EdiGene Inc. - Product / Service
• Exhibit 130: EdiGene Inc. - Key offerings
• 12.9 ElevateBio
• Exhibit 131: ElevateBio - Overview
• Exhibit 132: ElevateBio - Product / Service
• Exhibit 133: ElevateBio - Key offerings
• 12.10 GenScript Biotech Corp.
• Exhibit 134: GenScript Biotech Corp. - Overview
• Exhibit 135: GenScript Biotech Corp. - Business segments
• Exhibit 136: GenScript Biotech Corp. - Key news
• Exhibit 137: GenScript Biotech Corp. - Key offerings
• Exhibit 138: GenScript Biotech Corp. - Segment focus
• 12.11 Intellia Therapeutics Inc.
• Exhibit 139: Intellia Therapeutics Inc. - Overview
• Exhibit 140: Intellia Therapeutics Inc. - Product / Service
• Exhibit 141: Intellia Therapeutics Inc. - Key offerings
• 12.12 Maravai LifeSciences Holdings Inc.
• Exhibit 142: Maravai LifeSciences Holdings Inc. - Overview
• Exhibit 143: Maravai LifeSciences Holdings Inc. - Business segments
• Exhibit 144: Maravai LifeSciences Holdings Inc. - Key offerings
• Exhibit 145: Maravai LifeSciences Holdings Inc. - Segment focus
• 12.13 Merck KGaA
• Exhibit 146: Merck KGaA - Overview
• Exhibit 147: Merck KGaA - Business segments
• Exhibit 148: Merck KGaA - Key news
• Exhibit 149: Merck KGaA - Key offerings
• Exhibit 150: Merck KGaA - Segment focus
• 12.14 PerkinElmer Inc
• Exhibit 151: PerkinElmer Inc - Overview
• Exhibit 152: PerkinElmer Inc - Business segments
• Exhibit 153: PerkinElmer Inc - Key news
• Exhibit 154: PerkinElmer Inc - Key offerings
• Exhibit 155: PerkinElmer Inc - Segment focus
• 12.15 ProQR Therapeutics NV
• Exhibit 156: ProQR Therapeutics NV - Overview
• Exhibit 157: ProQR Therapeutics NV - Product / Service
• Exhibit 158: ProQR Therapeutics NV - Key offerings
• 12.16 Shape Therapeutics Inc.
• Exhibit 159: Shape Therapeutics Inc. - Overview
• Exhibit 160: Shape Therapeutics Inc. - Product / Service
• Exhibit 161: Shape Therapeutics Inc. - Key offerings
• 12.17 Synthego Corp.
• Exhibit 162: Synthego Corp. - Overview
• Exhibit 163: Synthego Corp. - Product / Service
• Exhibit 164: Synthego Corp. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 165: Inclusions checklist
• Exhibit 166: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 167: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 168: Research methodology
• Exhibit 169: Validation techniques employed for market sizing
• Exhibit 170: Information sources
• 13.5 List of abbreviations
• Exhibit 171: List of abbreviations